Allergan Board Must Pay For $600M DOJ Deal, Suit Says
An Allergan Inc. shareholder has sued to force members of the company's board to shoulder the burden of a $600 million settlement with the U.S. Department of Justice over off-label uses...To view the full article, register now.
Already a subscriber? Click here to view full article